About Us

Sirius Genomics is a private biotechnology company based in Vancouver, British Columbia. By correlating genes to phenotypes, we are developing DNA-based diagnostic (Dx) and pharmacogenetic (PGx) tests for critical care. Our product focus is currently concentrated on the development of Dx and PGx tests for sepsis, a systemic blood infection.

Founded in 2001 by Drs. James Russell and Keith Walley, Sirius Genomics has expanded and developed its internal talent and resources to include complementary scientific, medical and business expertise that is capable of efficiently bringing unique, valuable Dx and PGx products to the critical care market.